Purpose The purpose of this study was to estimate the optimal size of visual field test for detecting longitudinal changes in retinitis pigmentosa (RP) by dividing the visual field. Methods We reviewed the results of 10°static visual field tests in 19 eyes of 19 RP patients. Sixty-eight numeric value points were divided into two area types: concentric areas (A1, A1-2, A1-3, A1-4, A1-5, A1-6) and circular areas (A1, A2, A3, A4, A5, A6). Serial values of mean sensitivity in each area of each patient were analyzed by linear regression.
Introduction
Retinitis pigmentosa (RP) is a heterogenous hereditary disease that primarily affects rod photoreceptors. As a consequence of rod photoreceptor death, patients experience night blindness and peripheral visual field loss in the early stages of the disease [1] . Although cone photoreceptors are not the primarily affected cells in typical RP, the extensive rod photoreceptor loss eventually leads to cone photoreceptor death. The loss of cone photoreceptors results in central visual field loss and visual acuity impairment, which are more critical than night blindness or peripheral visual field loss. Thus, it is important to evaluate the remaining function of the cone photoreceptors in RP patients.
Several basic and clinical studies were either conducted or are ongoing to develop a potential therapy for RP. However, to date, no such therapy has been forthcoming. One possible reason for the difficulty in developing novel treatments for RP is the absence of a practical evaluation system of disease progression, which is difficult because visual acuity does not change for a long time, electroretinography has large interexamination variations, and kinetic perimetry is not suitable for quantitative analysis. It may thus be essential to establish a strategy with higher accuracy and sensitivity for detecting changes in visual function. Automated static perimetry with the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Inc. Dublin, CA, USA) is one such potential method [2] [3] [4] [5] [6] [7] . Large clinical trials used the HFA 30-2 program as a primary endpoint to examine the effects of treatment [8, 9] . Other authors demonstrated the efficacy of the preinstalled 10-2 HFA program [3] that measures 68 points within the central 10°. Because other programs use fewer measuring points in the central area (for example, the 30-2 program lays only 12 points within the central 10°), the 10-2 program may be better suited for evaluating central visual function [10] .
Analysis of visual field divided into specific areas, as proposed for glaucoma and shown to successfully detect changes in threshold value [11] [12] [13] , can help in more precisely evaluating visual field regression in RP patients. Although the areas defined in glaucoma studies are usually based on the assumed projection of retinal nerve fibers [11, 12, 14] , the visual field of RP patients tends to show concentric restrictions. Iijima reports that the central four points or 12 points would be helpful to assess RP progression [15] . Therefore, we hypothesized that concentrically divided areas with the 10-2 program may help obtain an optimal size in a visual field test designed to observe RP patients.
Four methods are commonly used for progression analysis of the visual field: clinical judgment, defect classification systems, event analyses, and trend analysis [16] . Trend analysis usually uses a linear regression model on the premise that sensitivity threshold declines linearly; further, a linear regression model enables identification of the validity of tests in each individual, as well as the annual rate of decline. Thus, in this study, we retrospectively analyzed the mean sensitivity value in each concentrically divided area of HFA 10-2 testing and investigated the efficacy by using a linear regression model in RP patients.
Methods

Patients
All procedures conformed to the tenets of the Declaration of Helsinki, and the study design was approved by the Institutional Review Board at Kyoto University Graduate School of Medicine. The review board waived the need for written informed consent, because the study design comprised a retrospective chart review. We selected typical RP patients who had been consistently (C5 tests over C3.5 years) examined with the HFA 10-2 SITA standard program. The first set of HFA data of each patient was not included in the analysis in order to overcome the learning effect. Data sets with fixation-loss scores of C20 % or either false-positive or false-negative errors of C33 % were also discarded [17] . The diagnosis of RP was made based on night blindness, characteristic fundus appearance, a concentric or ring-shaped scotoma, and low electroretinogram amplitudes in rods. Cone-rod dystrophy, crystalline dystrophy, or other inherited retinal diseases were excluded. Patients who underwent any intervention, e.g., cataract surgery, during the follow-up period were also excluded.
If both eyes of an individual were eligible, the eye with the better visual acuity was included in the analysis. As a result, 19 eyes of 19 RP patients were studied. The I-4 isopters of Goldmann perimetry in all patients showed central constriction within the central 10°, both with and without peripheral visual field islands.
Division and analysis of the 10-2 program
For analysis of each area, the 68 measuring points of the HFA 10-2 program were divided by six circular lines (Fig. 1a, b) . Following this, six concentric areas were defined: A1, A1-2, A1-3, A1-4, A1-5, and A1-6 (Fig. 1c) , and six circular areas: A1, A2, A3, A4, A5, and A6) (Fig. 1d) .
Analyses of the areas were performed based on the numeric value obtained from the results of each HFA field test (Fig. 1a) . Each numeric value represents the sensitivity (dB) at each point, and the mean sensitivity of each area was calculated by averaging the numeric values included in each area. Serial values of the mean sensitivity in each eye were analyzed with univariate linear regression, and annual rates of decline (dB/year) and R 2 values were estimated for each area in each eye.
Other parameters
Best-corrected visual acuity was measured with a Landolt chart and converted to a logarithm of the minimum angle of resolution. Optical coherence tomography (OCT) images were obtained from all patients by using Spectralis ? OCT (Heidelberg Engineering, Heidelberg, Germany) at the end of the follow-up period. We measured the length of the junction between the inner and outer segments (IS/ OS) manually in 30°cross scans.
Statistics
All data were analyzed as nonparametric data, except linear regression, and all data are shown as median and range because our sample size was too small to assume normal distribution. Shapiro-Wilk tests rejected the possibility of normal distribution in the follow-up period (P = 0.00017), number of visual field tests (P = 0.002), length of IS/OS (P \ 0.000001), visual acuity at initial (P = 0.005), visual acuity at final (P = 0.025), R 2 value of A1 (P = 0.034), and annual rate of decline in A1 (P = 0.046), A3 (P = 0.001), A4 (P = 0.003), and A5 (P = 0.026). Linear regression analysis was conducted to estimate the R 2 and the annual rate of decline. The mean deviation (MD) for the central 10-2 visual field was calculated from the total deviation with the Humphrey STATPAC. Bivariate correlations between areas in visual acuity and mean sensitivity were estimated with Spearman rank-correlation coefficient.
The Friedman test and the Mann-Whitney U test were performed, respectively, to investigate variance of annual rates and R 2 values for each area and to compare lengths of the IS/OS line of the two independent groups. We performed all statistical analyses using PASW Statistics version 17.0 (SPSS, Chicago, IL, USA).
Results
Demographic and clinical characteristics of cases in the study are summarized in Table 1 . Median age at the beginning of follow-up was 51 (range 29-75) years. Median follow-up was 4.5 (range 3.5-8) years, and median number of visual field tests during the follow-up period was six (range five to eight).
Concentric area analysis
The R 2 value demonstrates how closely the data set conformed to the linear regression. To elucidate the best size of the visual field tests that reveals disease progression in RP patients, linear regression analysis was performed in each concentric area (A1, A1-2, A1-3, A1-4, A1-5, and Although there was no significant difference between areas (P = 0.590), the median R 2 value was highest in A1. In ten eyes, the best R 2 value was seen in A1 (Fig. 2a) . Interestingly, R 2 values showed a bipolar distribution in both extremes; values were low in the intermediate areas of A1-2, A1-3, and A1-4, whereas three eyes had the best fit in A1-5 and four eyes in A1-6 (Fig. 2a) . When the eyes were divided into two groups, those with the best fit in A1, A1-2, or A1-3, and those with the best fit in A1-4, A1-5, or A1-6, eyes in the first group (Fig. 3 ) had a significantly (P = 0.030) shorter IS/OS line [186.25 lm (range 0-1136.5)] than those in the latter group (Fig. 4) [847.5 lm (range 0-5552.5)].
Circular area analysis
To illuminate the pattern of visual field defects within the central 10°, we performed circular area analysis (Fig. 1d) . Both the median annual rate of decline in A1-A6 were (range -2.276 to 0.360) dB/year, respectively. Although there was no significant difference between areas (P = 0.586), seven eyes showed the highest rate of decline in A1 (Fig. 2b) . As Fig. 2b also showed bipolar distribution in both extremes, we divided eyes into two groups, namely, eyes with disease progression most evident in A1, A2, or A3 and those with progression most evident in A4, A5, or A6. Eyes in the former group had a significantly (P = 0.034) shorter IS/OS line [0 lm (range 0-1,236)] than did eyes in the latter group [847.5 lm (range 0-5,552.5)].
Difference between visual acuity and visual field
To clarify the significance of measuring the visual field in RP patients, we calculated bivariate correlations between visual acuity and mean sensitivity in the areas. Neither did mean sensitivity in A1 at the initial visit correlate with visual acuity at the same time (r s = -0.386, P = 0.102), nor did it correlate with visual acuity at the final visit (r s = -0.408, P = 0.083). Mean sensitivity in A1-A6 showed no correlation with visual acuity at either the initial (r s = -0.041, P = 0.867) or the final visit (r s = -0.154, P = 0.528).
Discussion
Fitting to the regression line and disease progression rates in many eyes were both highest in A1. However, for some junction between the inner and outer segments of photoreceptors in the entire macular area. e Best R 2 value in A1-6; f greatest disease progression in A5 patients, the entire 10°area (A1-A6) or peripheral area (A5 or A6) would have been better suited for such assessment, as these patients showed moderate remaining morphology in the outer retina. This suggests that the optimal size of the visual field test may differ depending on RP severity.
The visual field of RP patients typically shows a ringshaped scotoma, which gradually advances to a severe visual field defect, leaving only the central 10°of sight. Thus, evaluating the remaining visual field in the central 10°may be a reasonable option for either detecting or comparing further disease progression in RP patients at an advanced stage. In a small study, Nakazawa et al. report the beneficial effects of treatment with the calcium-channelblocker (Ca 2? ) blocker nilvadipine in RP patients using HFA 10-2 scores as a primary outcome [7] . It has not been elucidated, however, whether measuring the 10°visual field is suitable for a follow-up of RP patients in any disease stage. Some patients may retain a large visual field, whereas others may show a visual field \5°, depending on the disease stage. To identify the most suitable visual field testing strategy for RP patients, results of the HFA 10-2 SITA standard program were segmented and analyzed retrospectively in this study.
Statistically, an increase in the number of measurement points generally results in a smaller variance. Thus, it is possible that the mean sensitivity of the total 68 points (A1-A6) would better fit the regression line than that of smaller areas. However, we found that 53 % of cases showed the best R 2 value in A1. This suggests that, in many cases, it should be possible to detect overall changes in the visual field in RP patients by monitoring the changes in A1 only rather than in the entire 10°area. On the other hand, some eyes showed the lowest variability in the entire 10°a rea. This bipolar distribution of the R 2 values encouraged us to further investigate the differences in the eyes included in this study, because a previous report shows that termination of the IS/OS line in OCT images corresponded to a sensitivity loss of -10 dB in HFA [18] . Thus, we investigated the correlation between HFA results and OCT images. We found that, when assessed using the 10-2 program, eyes with low variability in the inner areas (A1-A3) had a shorter IS/OS line. In other words, our results indicate that monitoring the smaller areas in advanced cases with shorter IS/OS and residual IS/OS lines might be a criterion in selecting visual field test protocols. Furthermore, circular areas were evaluated to gain insight into the areas in which eyes with RP showed the most severe regression of retinal sensitivity. Interestingly, eyes showing the greatest disease progression also showed bipolar distribution. We found that when assessed using the 10-2 program, eyes with evident disease progression in inner areas (A1, A2, and A3) had a shorter IS/OS line. In addition to the correlation between termination of the IS/OS line in OCT images and sensitivity loss of -10 dB in HFA, another report demonstrates that termination of the IS/OS was shortened by 0.16 mm over a 22.5-month period [5] . This suggests that retinal sensitivity in HFA would show a great regression in the area of termination in the IS/ OS of each eye.
This study has several limitations, including its retrospective design, small sample size, and possible selection bias based on inclusion of only those patients who underwent HFA for a long period of time. Also, eyes assessed in this study had a small visual field, which was limited to within the central 10°, either with or without far peripheral islands. Some younger patients with RP have visual fields larger than the central 10°section analyzed in this study. Had such patients been included in the study, distribution of the best fitting area or the most progressive area would likely have shifted to more peripheral areas, resulting in the 30-2 program being more suitable for assessment than the 10-2 program. In addition, we know that there is a difference between visual acuity and visual field. Visual acuity is a point function of the fovea, whereas visual field is an indicator of 2D visual function. Our results show that mean sensitivity in the central four points (A1) and the entire area of 10°(A1-A6) did not correlate with visual acuity. However, Iijma reports that the mean sensitivity of the central four points was correlated with visual acuity [15] . Because the measured points of A1 were located near the foveal center, the mean value may have had characteristics similar to visual acuity. Thus, when using the A1 parameter, one should consider that the findings may represent visual acuity rather than a visual field test.
We were unable to conclude what the optimal size of visual field testing was, and this may be due to the fact that the most reliable visual field testing method for monitoring RP progression may differ depending on each case and that to augment data, the different visual field sizes need to be monitored as well, depending on the remaining structure or function of the individual retina. Further studies are needed to optimize visual field tests for the purpose of effective follow-up of patients with RP and for designing clinical trials to examine the efficacy of potential treatment options.
